Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

Zobacz

español (ES) (239.85 KB - PDF)

Zobacz

čeština (CS) (283.94 KB - PDF)

Zobacz

dansk (DA) (239 KB - PDF)

Zobacz

Deutsch (DE) (241.8 KB - PDF)

Zobacz

eesti (ET) (237.14 KB - PDF)

Zobacz

ελληνικά (EL) (282.67 KB - PDF)

Zobacz

français (FR) (245.68 KB - PDF)

Zobacz

italiano (IT) (238.08 KB - PDF)

Zobacz

latviešu (LV) (283.06 KB - PDF)

Zobacz

lietuvių (LT) (251.47 KB - PDF)

Zobacz

magyar (HU) (253.42 KB - PDF)

Zobacz

Malti (MT) (265.77 KB - PDF)

Zobacz

Nederlands (NL) (217.72 KB - PDF)

Zobacz

polski (PL) (282.55 KB - PDF)

Zobacz

português (PT) (218.29 KB - PDF)

Zobacz

română (RO) (242.81 KB - PDF)

Zobacz

slovenčina (SK) (260.4 KB - PDF)

Zobacz

slovenščina (SL) (252.65 KB - PDF)

Zobacz

suomi (FI) (237.94 KB - PDF)

Zobacz

svenska (SV) (239.22 KB - PDF)

Zobacz

Product information

български (BG) (1.12 MB - PDF)

Zobacz

español (ES) (413.23 KB - PDF)

Zobacz

čeština (CS) (559.01 KB - PDF)

Zobacz

dansk (DA) (619.26 KB - PDF)

Zobacz

Deutsch (DE) (409.78 KB - PDF)

Zobacz

eesti (ET) (394.94 KB - PDF)

Zobacz

ελληνικά (EL) (1.78 MB - PDF)

Zobacz

français (FR) (455.26 KB - PDF)

Zobacz

italiano (IT) (432.39 KB - PDF)

Zobacz

latviešu (LV) (543.86 KB - PDF)

Zobacz

lietuvių (LT) (475.04 KB - PDF)

Zobacz

magyar (HU) (577.53 KB - PDF)

Zobacz

Malti (MT) (631.26 KB - PDF)

Zobacz

Nederlands (NL) (419.67 KB - PDF)

Zobacz

polski (PL) (601.64 KB - PDF)

Zobacz

português (PT) (402.62 KB - PDF)

Zobacz

română (RO) (490.98 KB - PDF)

Zobacz

slovenčina (SK) (616.03 KB - PDF)

Zobacz

slovenščina (SL) (568.91 KB - PDF)

Zobacz

suomi (FI) (408.3 KB - PDF)

Zobacz

svenska (SV) (413.86 KB - PDF)

Zobacz

Íslenska (IS) (418.64 KB - PDF)

Zobacz

norsk (NO) (405.73 KB - PDF)

Zobacz
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 KB - PDF)

Zobacz

español (ES) (148.22 KB - PDF)

Zobacz

čeština (CS) (192.56 KB - PDF)

Zobacz

dansk (DA) (151.57 KB - PDF)

Zobacz

Deutsch (DE) (152.17 KB - PDF)

Zobacz

eesti (ET) (147.88 KB - PDF)

Zobacz

ελληνικά (EL) (200.73 KB - PDF)

Zobacz

français (FR) (474.14 KB - PDF)

Zobacz

italiano (IT) (148.51 KB - PDF)

Zobacz

latviešu (LV) (202.11 KB - PDF)

Zobacz

lietuvių (LT) (191.42 KB - PDF)

Zobacz

magyar (HU) (188.69 KB - PDF)

Zobacz

Malti (MT) (194.75 KB - PDF)

Zobacz

Nederlands (NL) (151.46 KB - PDF)

Zobacz

polski (PL) (176.01 KB - PDF)

Zobacz

português (PT) (151.81 KB - PDF)

Zobacz

română (RO) (188.05 KB - PDF)

Zobacz

slovenčina (SK) (195.92 KB - PDF)

Zobacz

slovenščina (SL) (189.87 KB - PDF)

Zobacz

suomi (FI) (147.96 KB - PDF)

Zobacz

svenska (SV) (151.54 KB - PDF)

Zobacz

Íslenska (IS) (151.76 KB - PDF)

Zobacz

norsk (NO) (148.31 KB - PDF)

Zobacz

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page